Nuvectis Pharma, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Nuvectis Pharma, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Status Update

Aug 12, 2025

Press release

Transcript

Q2 2025

Aug 5, 2025

Earnings release8-K

Quarterly report10-Q

Corporate Presentation

Jun 13, 2025

Slides

Q1 2025

May 6, 2025

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Feb 25, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 5, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 6, 2024

Earnings release8-K

Quarterly report10-Q

Q1 2024

May 7, 2024

Earnings release8-K

Quarterly report10-Q

Corporate Presentation

Apr 15, 2024

Slides

2023

Q4 2023

Mar 5, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 8, 2023

Earnings release8-K

Quarterly report10-Q

Q2 2023

Aug 9, 2023

Earnings release8-K

Quarterly report10-Q

Q1 2023

May 10, 2023

Earnings release8-K

Quarterly report10-Q

2022

Q4 2022

Mar 7, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 8, 2022

Earnings release8-K

Quarterly report10-Q

Q2 2022

Aug 5, 2022

Earnings release8-K

Quarterly report10-Q

Q1 2022

May 10, 2022

Earnings release8-K

Quarterly report10-Q

2021

Q4 2021

Mar 22, 2022

Annual report10-K

Earnings release8-K